As of Jun 18
| +0.03 / +2.40%|
The 1 analysts offering 12-month price forecasts for CytRx Corp have a median target of 4.50, with a high estimate of 4.50 and a low estimate of 4.50. The median estimate represents a +251.56% increase from the last price of 1.28.
The current consensus among 1 polled investment analysts is to Buy stock in CytRx Corp. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.